IDEAS home Printed from https://ideas.repec.org/a/wsi/ijimxx/v19y2015i03ns1363919615400034.html
   My bibliography  Save this article

Combination Therapies Or Standalone Interventions? Innovation Options For Pharmaceutical Firms Fighting Cancer

Author

Listed:
  • GUNJAN BHARDWAJ

    (European Business School, Gustav-Stresemann-Ring 3, 65189 Wiesbaden, Germany)

  • ANSHIT AGRAWAL

    (Innoplexus, India, MG Road, Gurgaon, Haryana, 122002, India)

  • RUPESH TYAGI

    (Innoplexus, India, MG Road, Gurgaon, Haryana, 122002, India)

Abstract

Innovation is key to the pharma model, from an initial discovery to the final development of a marketable drug. Here, we explore the innovation options in the fiercely contested therapeutic area of Oncology. We studied clinical development of drugs targeting PD-1 and PD-L1 pathway. In this interesting contest, companies seem to be focusing on standalone interventions (exploratory innovation) and combination therapy (exploitative innovation) in clinical development. Merck Sharp and Dohme, having a relatively weaker oncology pipeline seems to take exploratory approach of standalone intervention. However for some indications, MSD seems to harness exploitative innovation approach through combination therapies by collaborating with external partners. AstraZeneca in contrast seems to focus on exploitative approach using its strong oncology pipeline for combination therapies. Our work provides a framework to understand exploratory (standalone) and exploitative (combination therapy) innovation approaches and their relationship to capability, scientific networks and market access for a company entering a fiercely contested pharmaceutical market.

Suggested Citation

  • Gunjan Bhardwaj & Anshit Agrawal & Rupesh Tyagi, 2015. "Combination Therapies Or Standalone Interventions? Innovation Options For Pharmaceutical Firms Fighting Cancer," International Journal of Innovation Management (ijim), World Scientific Publishing Co. Pte. Ltd., vol. 19(03), pages 1-16.
    • Handle: RePEc:wsi:ijimxx:v:19:y:2015:i:03:n:s1363919615400034
    DOI: 10.1142/S1363919615400034
    as

    Download full text from publisher

    File URL: http://www.worldscientific.com/doi/abs/10.1142/S1363919615400034
    Download Restriction: Access to full text is restricted to subscribers
    File URL: https://libkey.io/10.1142/S1363919615400034?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wsi:ijimxx:v:19:y:2015:i:03:n:s1363919615400034. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Tai Tone Lim (email available below). General contact details of provider: http://www.worldscinet.com/ijim/ijim.shtml .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.